68 related articles for article (PubMed ID: 2207456)
21. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
[TBL] [Abstract][Full Text] [Related]
22. Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients.
Sierra J; Grañena A; García J; Valls A; Carreras E; Rovira M; Canals C; Martínez E; Puntí C; Algara M
Bone Marrow Transplant; 1993 Nov; 12(5):517-23. PubMed ID: 8298563
[TBL] [Abstract][Full Text] [Related]
23. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
[TBL] [Abstract][Full Text] [Related]
24. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
25. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
27. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation.
Haas R; Gericke G; Witt B; Cayeux S; Hunstein W
Exp Hematol; 1993 Jan; 21(1):109-13. PubMed ID: 7678083
[TBL] [Abstract][Full Text] [Related]
28. Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias.
Suttorp M; Schmitz N; Leuschner S; Appelt M; Rister M; Schaub J
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():144-8. PubMed ID: 2697428
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
30. [Bone marrow autotransplantation in patients with acute myeloblastic leukemia in primary remission].
Richard C; Iriondo A; Baro J; Conde E; Hermosa V; Alsar MJ; Gómez Casares MT; Muruzabal MJ; Pérez Encinas M; Zubizarreta A
Med Clin (Barc); 1990 Sep; 95(9):324-8. PubMed ID: 2280616
[TBL] [Abstract][Full Text] [Related]
31. High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?
Dicke KA; Spinolo JA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():184-6. PubMed ID: 2653500
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT).
Vignetti M; Rondelli R; Locatelli F; Lanino E; Miniero R; Rossetti F; Meloni G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():59-62. PubMed ID: 8932801
[TBL] [Abstract][Full Text] [Related]
33. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
34. Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation.
Wei C; Thyagiarajan M; Hunt L; Cox R; Bradley K; Elson R; Hamilton-Shield J; Stevens M; Crowne E
Clin Endocrinol (Oxf); 2015 Jan; 82(1):59-67. PubMed ID: 25132503
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
36. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
[TBL] [Abstract][Full Text] [Related]
38. Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission.
Verdonck LF; Dekker AW; de Gast GC; Lokhorst HM; Nieuwenhuis HK
J Clin Oncol; 1992 Apr; 10(4):644-6. PubMed ID: 1548528
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the outcome of ABMT in first remission acute myeloid and lymphoblastic leukemia in a single centre.
McMillan AK; Goldstone AH; Chopra R; Linch DC
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():72. PubMed ID: 2202472
[No Abstract] [Full Text] [Related]
40. Persistence of impaired pancreatic beta-cell function in children treated for acute lymphoblastic leukaemia.
Mohn A; Di Marzio A; Capanna R; Fioritoni G; Chiarelli F
Lancet; 2004 Jan; 363(9403):127-8. PubMed ID: 14726167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
